EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy

Allergy today is a public health concern of pandemic proportions, affecting more than 150 million people in Europe alone. In view of epidemiological trends, the European Academy of Allergy and Clinical Immunology (EAACI) predicts that within the next few decades, more than half of the European popul...

Descripción completa

Detalles Bibliográficos
Autores principales: Calderon, Moises A, Demoly, Pascal, Gerth van Wijk, Roy, Bousquet, Jean, Sheikh, Aziz, Frew, Anthony, Scadding, Glenis, Bachert, Claus, Malling, Hans J, Valenta, Rudolph, Bilo, Beatrice, Nieto, Antonio, Akdis, Cezmi, Just, Jocelyne, Vidal, Carmen, Varga, Eva M, Alvarez-Cuesta, Emilio, Bohle, Barbara, Bufe, Albrecht, Canonica, Walter G, Cardona, Victoria, Dahl, Ronald, Didier, Alain, Durham, Stephen R, Eng, Peter, Fernandez-Rivas, Montserrat, Jacobsen, Lars, Jutel, Marek, Kleine-Tebbe, Jörg, Klimek, Ludger, Lötvall, Jan, Moreno, Carmen, Mosges, Ralph, Muraro, Antonella, Niggemann, Bodo, Pajno, Giovanni, Passalacqua, Giovanni, Pfaar, Oliver, Rak, Sabina, Senna, Gianenrico, Senti, Gabriela, Valovirta, Erkka, van Hage, Marianne, Virchow, Johannes C, Wahn, Ulrich, Papadopoulos, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Position Article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514324/
https://www.ncbi.nlm.nih.gov/pubmed/23110958
http://dx.doi.org/10.1186/2045-7022-2-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514324/
https://www.ncbi.nlm.nih.gov/pubmed/23110958
http://dx.doi.org/10.1186/2045-7022-2-20

Ejemplares similares